Consistently, in our study, we proved that PL resulted in the reduction of the p-PI3K/p-AKT/p-mTOR/JAK2/p-STAT3 and the augment of the p-p38/p-ERK1/2/p-JNK in the H22 tumor-bearing mice. The gene discussed is JAK2; the disease is neoplasm.